Drug profile

The FDA adverse-event record for Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

18 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. See the species affected, top reactions, and outcomes below.

18
adverse-event reports
22.2%
death-coded share
Dog
most-reported species
5
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
18
Total Reports
4
Deaths Reported
22.2%
Death Rate

Active Ingredients

Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

Administration Routes

SubcutaneousParenteralUnknown

Species Affected

Dog 18

Most Affected Breeds

Retriever - Labrador 2
Pug 2
Spaniel - Springer English 1
Rottweiler 1
Spaniel - Cocker American 1
American Pit Bull Terrier 1
Maltese 1
Boxer (German Boxer) 1
Corgi (unspecified) 1
Shepherd Dog - German 1

Most Reported Reactions

Vomiting 5
Other abnormal test result NOS 4
Lack of efficacy - NOS 3
Death by euthanasia 3
Anaphylaxis 3
Anorexia 2
Diarrhoea 2
Panting 2
Elevated temperature 2
Lateral recumbency 1
Bradycardia 1
Tachycardia 1

Outcome Breakdown

Recovered/Normal
7 (38.9%)
Outcome Unknown
4 (22.2%)
Ongoing
3 (16.7%)
Euthanized
3 (16.7%)
Died
1 (5.6%)

Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract Adverse Event Insights

18 reports name Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract; 4 recorded a death outcome (22.2% of reported events, not a population-level mortality rate). Active ingredient: Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine, Mlv-Kv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. Administration routes: Subcutaneous, Parenteral, Unknown.

By species: Dog (18 reports). By breed: Retriever - Labrador (2), Pug (2), Spaniel - Springer English (1).

Leading clinical signs: Vomiting (5), Other abnormal test result NOS (4), Lack of efficacy - NOS (3), Death by euthanasia (3). Outcome, 18 coded reports: Recovered/Normal leads at 38.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.